ECAT insider sells 44,604 shares at $15.85, holds 26.9M
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner on a Form 4.
Rhea-AI Filing Summary
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner on a Form 4. On 11/17/2025, the reporting person executed a sale of 44,604 shares of common stock at a price of $15.85 per share. After this transaction, the reporting person reported 26,863,085 shares of ECAT common stock beneficially owned in an indirect capacity. The filing reflects a routine update to the insider’s reported holdings and confirms the relationship as a 10% owner of the trust.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 44,604 | $15.85 | $707K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ECAT report on this Form 4?
The filing reports that a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT) sold 44,604 shares of common stock on 11/17/2025.
What is the relationship of the reporting person to BlackRock ESG Capital Allocation Term Trust (ECAT)?
The reporting person is identified as a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT).
Were any derivative securities of ECAT reported in this Form 4?
The section for derivative securities is included in the form, but no specific derivative transactions or holdings are detailed in the provided content.
Is the ownership reported on this ECAT Form 4 direct or indirect?
The 26,863,085 ECAT shares beneficially owned after the transaction are reported as indirect ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.